Market Research Reports

1. The US Clinical Research Market Introduction

2. The US Clinical Research Market Value Chain

3. The US Clinical Research Market Size by Revenue, 2006-2012

4. The US Clinical Research Market Segmentation by Major Therapeutic Areas, 2006-2012

5. The US Oncology Clinical Research Market

5.1. The US Oncology Clinical Research Market Size by Revenue, 2006-2012

5.2. The US Oncology Clinical Research Market Segmentation, 2006-2012

5.2.1. The US Breast Cancer Clinical Research Market Size by Revenue, 2006-2012

5.2.2. The US Breast Cancer Clinical Research Market Future Projections, 2013-2017

5.2.3. The US Lung Cancer Clinical Research Market, 2006-2012

5.2.4. The US Lung Cancer Clinical Research Market Future Projections, 2013-2017

5.2.5. The US Leukemia Clinical Research Market, 2006-2012

5.2.6. The US Leukemia Clinical Research Market Future Projections, 2013-2017

5.2.7. The US Prostate Cancer Clinical Research Market, 2006-2012

5.2.8. The US Prostate Cancer Clinical Research Market Future Projections, 2013-2017

5.2.9. The US Non-Small Cell Lung Cancer Clinical Research Market Size by Revenue, 2006-2012

5.2.10. The US Non-Small Cell Lung Cancer Market Future Projections, 2013-2017

5.2.11. The US Other Kinds of Cancer Clinical Research Market Size By Revenue, 2006-2012

5.2.12. The US Other Kinds of Cancer Clinical Research Market Future Projections, 2013-2017

5.3. The US Oncology Clinical Research Market Future Outlook and Projections by Revenue, 2013-2017

6. The US Central Nervous System Clinical Research Market

6.1. The US Central Nervous System Clinical Research Market Size by Revenue, 2006-2012

6.2. The US Central Nervous System Disorders Clinical Research Market Segmentation, 2006-2012

6.2.1. The US Strokes Clinical Research Market Size by Revenue, 2006-2012

6.2.2. The US Strokes Clinical Research Market Future Outlook and Projections by Revenue, 2013-2017

6.2.3. The US Schizophrenia Clinical Research Market Size by Revenue, 2006-2012

6.2.4. The US Schizophrenia Clinical Research Market Future Outlook and Projections by Revenue, 2013-2017

6.2.5. The US Alzheimer Clinical Research Market Size by Revenue, 2006-2012

6.2.6. The US Alzheimer Clinical Research Market Future Outlook and Projections, 2013-2017

6.2.7. The US Multiple Sclerosis Clinical Research Market Size by Revenue, 2006-2012

6.2.8. The US Multiple Sclerosis Clinical Research Market Future Outlook and Projections by Revenue, 2013-2017

6.2.9. The US Epilepsy Clinical Research Market Size by Revenue, 2006-2012

6.2.10. The US Epilepsy Clinical Research Market Future Outlook and Projections by Revenue, 2013-2017

6.2.11. The US Other Central Nervous System Disorders Clinical Research Market Size by Revenue, 2006-2012

6.2.12. The US Other Central Nervous System Disorders Clinical Research Market Future Outlook and Projections by Revenue, 2013-2017

6.3. The US Central Nervous System Clinical Research Market Future Outlook and Projections, 2006-2012

7. The US Cardiovascular Clinical Research Market

7.1. The US Cardiovascular Clinical Research Market Size by Revenue, 2006-2012

7.2. The US Cardiovascular Clinical Research Market Segmentation, 2006-2012

7.2.1. The US Coronary Artery Disease Clinical Research Market Size, 2006-2012

7.2.2. The US Coronary Artery Disease Clinical Research Market Future Outlook and Projections, 2013-2017

7.2.3. The US Heart Failures Clinical Research Market Size by Revenue, 2006-2012

7.2.4. The US Heart Failures Clinical Research Market Future Projections, 2013-2017

7.2.5. The US Other Cardiovascular Diseases Clinical Research Market Size by Revenue, 2006-2012

7.2.6. The US Other Cardiovascular Diseases Clinical Research Market Size Future Outlook and Projections, 2013-2017

7.3. The US Cardiovascular Clinical Research Market Future Outlook and Projections by Revenue, 2013-2017

8. The US Infectious Diseases Clinical Research Market

8.1. The US Infectious Diseases Clinical Research Market Size by Revenue, 2006-2012

8.2. The US Infectious Diseases Clinical Research Market Segmentation, 2006-2012

8.2.1. The US HIV/AIDS Clinical Research Market Size by Revenue, 2006-2012

8.2.2. The US HIV/AIDS Clinical Research Market Future Outlook and Projections, 2013-2017

8.2.3. The US Hepatitis (A, B and C) Clinical Research Market Size by Revenue, 2006-2012

8.2.4. The US Hepatitis (A, B and C) Clinical Research Market Future Outlook and Projections by revenue, 2013-2017

8.2.5. The US Other Infectious Diseases Clinical Research Market Size, 2006-2012

8.2.6. The US Other Infectious Diseases Clinical Research Market Future Outlook and Projections, 2006-2012

8.3. The US Infectious Diseases Clinical Research Market Future Outlook and Projections By Revenue, 2013-2017

9. The US Metabolic Disorders Clinical Research Market

9.1. The US Metabolic Disorders Clinical Research Market Size by Revenue, 2006-2012

9.2. The US Metabolic Disorders Clinical Research Market Segmentation, 2006-2012

9.2.1. The US Diabetes Clinical Research Market Size by Revenue, 2006-2012

9.2.2. The US Diabetes Clinical Research Market Future Outlook and Projections by Revenue, 2013-2017

9.2.3. The US Other Metabolic Disorders Clinical Research Market Size by Revenue, 2006-2012

9.2.4. The US Other Metabolic Disorders Clinical Research Market Future Outlook and Projections, 2013-2017

9.3. The US Metabolic Disorders Clinical Research Market Future Outlook and Projections, 2013-2017

10. The US Other Therapeutic Area Clinical Research Market

10.1. The US Other Therapeutic Area Clinical Research Market Size by Revenue, 2006-2012

10.2. The US Other Therapeutic Area Clinical Research Market Future Outlook and Projections, 2013—2017

11. FDA Rules Governing the US Clinical Research Market

12. Trends and Developments in the US Clinical Research Market

Reduced Government Spending on Clinical Research

Off shoring Clinical trials to Emergent Markets

Evolution of E-clinical trials

Patent Expiry of Several Branded Drugs

Privatization of CROs

Strategic Alliances between Pharmaceutical Companies and CROs

13. Opportunities, Drivers and Restraints

Opportunities

Drivers

Restraints

14. Role of Academic Institutes in the US in Conducting Clinical Research

15. Market Share of Major Players in the US Clinical Research Market, 2012

16. Company Profiles of the Major Players

16.1. Quintiles

Company Overview

Business Strategies

Financial Performance

16.2. Covance Inc. 

Company Overview

Business Strategies

Financial Performance

16.3. PPD

Company Overview

Business Strategies

Financial Performance

16.4. INC Research

Company Overview

Business Strategies

16.5. Inventiv Health Care

Company Overview

Business Strategies

Financial Performance

16.6. Parexel

Company Overview

Business Strategies

16.7. ICON

Company Overview

Business Strategies

Financial Performance

16.8. PRA

Company Overview

Business Strategies

17. The US Clinical Research Market Future Outlook and Projections, 2013-2017

17.1. Cause and Effect Relationship between Dependent and Independent Factors Prevailing In the Us Clinical Research Market

17.2. The US Clinical Research Market Future Projections, 2013-2017

18. Macro Economic and Industry factors: Historical and Projections

18.1. The US Pharmaceutical Companies Domestic R&D Expenditure, 2006-2017

18.2. The US GDP, 2006-2017

18.3. The US Aged population, 2006-2017

18.4. The US Health Expenditure, 2006-2017

18.5. NIH Funding to Clinical Research, 2006-2017

19. Appendix

19.1. Market Definitions

19.2. Abbreviations

19.3. Research Methodology

Data Collection Methods

Approach

Variables (Dependent and Independent) 

Multi Factor Based Sensitivity Model

Final Conclusion

19.4. Disclaimer

The US Clinical Research Market-Introduction Market Size Pages : 11 USD 100    Market Size Reports Market Size Reports

 1. The US Clinical Research Market Introduction

Table 1: The US Pharma Companies Spending Breakdown on Outsourcing across Various Phases of Clinical Research in percentage (%), 2008
Table 2: The US NIH Funding for Research and the Annual Cost of Care for Major Diseases in USD Billion, FY 2012
2. The US Clinical Research Market Value Chain
Figure 1: The US Clinical Research Market Value Chain
3. The US Clinical Research Market Size by Revenue, 2006-2012
Figure 2: The US Clinical Research Market Size on the Basis of Revenues in USD Million, 2006-2012
Table 3: The US Number of Clinical Studies Conducted in Units, 2006-2012
 

The US Clinical Research Market-Market Segmentation Pages : 113 USD 550    Market Size Reports Market Size Reports

 4. The US Clinical Research Market Segmentation by Major Therapeutic Areas, 2006-2012

Figure 3: The US Clinical Research Market Segmentation by Major Therapeutic Areas on the Basis of Revenue in Percentage (%), 2006-2012
Table 4: The US Number of Clinical Studies Funded by NIH in Units, 2006-2012
Table 5: The US Number of Clinical Studies Funded by Industry in Units, 2006-2012
Table 6: The US Number of Clinical Studies Funded by Other Federal Agencies in Units, 2006-2012
Table 7: The US Number of Clinical Studies Funded by All Other Associations, Societies in Units, 2006-2012
5. The US Oncology Clinical Research Market
5.1. The US Oncology Clinical Research Market Size by Revenue, 2006-2012
Figure 4: The US Oncology Clinical Research Market Size on the Basis of Revenues in USD Million, 2006-2012
Table 8: The US Number of Oncology Clinical Studies Conducted in Units, 2006-2012
5.2. The US Oncology Clinical Research Market Segmentation, 2006-2012
Figure 5: The US Oncology Clinical Research Market Segmentation by Major Therapeutic Areas on the Basis of Revenue in Percentage (%), 2006-2012
Table 9: The US NCI Spending on Research and Related Activities for Various Kinds of Cancer in USD Million, 2008-2010
5.2.1. The US Breast Cancer Clinical Research Market Size by Revenue, 2006-2012
Figure 6: The US Breast Cancer Clinical Research Market Size on the basis of Revenues in USD Million, 2006-2012
Table 10: The US Breast Cancer Clinical Studies Conducted in Units, 2006-2012
Table 11: The US Breast Cancer Incidence Rate per 100,000 Women, 2006-2009
Table 12: The US New Cases of Breast Cancer and the Number of Deaths per Day, 2012
5.2.2. The US Breast Cancer Clinical Research Market Future Projections, 2013-2017
Figure 7: The US Breast Cancer Clinical Research Market Future Projections on the Basis of Revenues in USD Million, 2013-2017
5.2.3. The US Lung Cancer Clinical Research Market, 2006-2012
Table 13: The US Lung Cancer Incidence Rate per 100,000 Persons, 2006-2009
Table 14: The US Lung Cancer Estimated New Cases in Men and Women, 2010 and 2012
Figure 8: The US Lung Cancer Clinical Research Market Size on the Basis of Revenues in USD Million, 2006-2012
Table 15: The US Lung Cancer Clinical Studies Conducted in Units, 2006-2012
5.2.4. The US Lung Cancer Clinical Research Market Future Projections, 2013-2017
Figure 9: The US Lung Cancer Clinical Research Market Future Projections on the Basis of Revenues in USD Million, 2013-2017
5.2.5. The US Leukemia Clinical Research Market, 2006-2012
Table 16: The US Prevalence of the Four Major Types of Leukemia as of January 01, 2009
Table 17: The US Estimated New Leukemia Cases, 2010 and 2012
Figure 10: The US Leukemia Clinical Research Market Size on the basis of Revenue in USD Million, 2006-2012
Table 18: The US Leukemia Clinical Studies Conducted in Units, 2006-2012
5.2.6. The US Leukemia Clinical Research Market Future Projections, 2013-2017
Figure 11: The US Leukemia Clinical Research Market Future Projections on the Basis of Revenues in USD Million, 2013-2017
5.2.7. The US Prostate Cancer Clinical Research Market, 2006-2012
Table 19: The US Prostate Cancer Incidence Rate per 100,000 Men, 2006-2009
Table 20: The US Prostate Cancer Estimated New Cases, 2010 and 2012
Figure 12: The US Prostate Cancer Clinical Research Market Size on the Basis of Revenues in USD Million, 2006-2012
Table 21: The US Prostate Cancer Clinical Studies Conducted in Units, 2006-2012
5.2.8. The US Prostate Cancer Clinical Research Market Future Projections, 2013-2017
Figure 13: The US Prostate Cancer Clinical Research Market Future Projections on the Basis of Revenues in USD Million, 2013-2017
5.2.9. The US Non-Small Cell Lung Cancer Clinical Research Market Size by Revenue, 2006-2012
Figure 14: The US Non Small Cell Lung Cancer Clinical Research Market Size on the Basis of Revenues in USD Million, 2006-2012
Table 22: The US Non Small Cell Lung Cancer Clinical Studies Conducted in Units, 2006-2012
5.2.10. The US Non-Small Cell Lung Cancer Market Future Projections, 2013-2017
Figure 15: The US Non-Small Cell Lung Cancer Clinical Research Market Future Projections on the Basis of Revenues in USD Million, 2013-2017
5.2.11. The US Other Kinds of Cancer Clinical Research Market Size By Revenue, 2006-2012
Figure 16: The US Other Kinds of Cancer Clinical Research Market Size on the basis of Revenues in USD Million, 2006-2012
5.2.12. The US Other Kinds of Cancer Clinical Research Market Future Projections, 2013-2017
Figure 17: The US Other Kinds of Cancer Clinical Research Market Future Projections on the Basis of Revenues in USD Million, 2013-2017
5.3. The US Oncology Clinical Research Market Future Outlook and Projections by Revenue, 2013-2017
Figure 18: The US Oncology Clinical Research Market Future Projections on the Basis of Revenues in USD Million, 2013-2017
6. The US Central Nervous System Clinical Research Market
6.1. The US Central Nervous System Clinical Research Market Size by Revenue, 2006-2012
Figure 19: The US Central Nervous System Clinical Research Market Size on The Basis of Revenues in USD Million, 2006-2012
Table 23: The US Central Nervous System Clinical Studies Conducted in Units, 2006-2012
6.2. The US Central Nervous System Disorders Clinical Research Market Segmentation, 2006-2012
Figure 20: The US Central Nervous System Clinical Research Market Segmentation by Major Therapeutic Areas on the Basis of Revenue in Percentage (%), 2006-2012
6.2.1. The US Strokes Clinical Research Market Size by Revenue, 2006-2012
Figure 21: The US Strokes Clinical Research Market Size on The Basis of Revenues in USD Million, 2006-2012
Table 24: The US Strokes Clinical Studies Conducted in Units, 2006-2012
6.2.2. The US Strokes Clinical Research Market Future Outlook and Projections by Revenue, 2013-2017
Figure 22: The US Strokes Clinical Research Market Future Projections on the Basis of Revenues in USD Million, 2013-2017
6.2.3. The US Schizophrenia Clinical Research Market Size by Revenue, 2006-2012
Figure 23: The US Schizophrenia Clinical Research Market Size on The Basis of Revenues in USD Million, 2006-2012
Table 25: The US Schizophrenia Clinical Studies Conducted in Units, 2006-2012
6.2.4. The US Schizophrenia Clinical Research Market Future Outlook and Projections by Revenue, 2013-2017
Figure 24: The US Schizophrenia Clinical Research Market Future Projections on the Basis of Revenues in USD Million, 2013-2017
6.2.5. The US Alzheimer Clinical Research Market Size by Revenue, 2006-2012
Figure 25: The US Alzheimer Clinical Research Market Size on the Basis of Revenue in USD Million, 2006-2012
Table 26: The US Alzheimer Clinical Studies Conducted in Units, 2006-2012
6.2.6. The US Alzheimer Clinical Research Market Future Outlook and Projections, 2013-2017
Figure 26: The US Alzheimer Clinical Research Market Future Projections on the Basis of Revenue in USD Million, 2013-2017
6.2.7. The US Multiple Sclerosis Clinical Research Market Size by Revenue, 2006-2012
Figure 27: The US Multiple Sclerosis Clinical Research Market Size on The Basis of Revenue in USD Million, 2006-2012
Table 27: The US Multiple Sclerosis Clinical Studies Conducted in Units, 2006-2012
6.2.8. The US Multiple Sclerosis Clinical Research Market Future Outlook and Projections by Revenue, 2013-2017
Figure 28: The US Multiple Sclerosis Clinical Research Market Future Projections on the Basis of Revenue in USD Million, 2013-2017
6.2.9. The US Epilepsy Clinical Research Market Size by Revenue, 2006-2012
Figure 29: The US Epilepsy Clinical Research Market Size on the Basis of Revenue in USD Million, 2006-2012
Table 28: The US Epilepsy Clinical Studies Conducted in Units, 2006-2012
6.2.10. The US Epilepsy Clinical Research Market Future Outlook and Projections by Revenue, 2013-2017
Figure 30: The US Epilepsy Clinical Research Market Future Projections on the Basis of Revenues in USD Million, 2013-2017
6.2.11. The US Other Central Nervous System Disorders Clinical Research Market Size by Revenue, 2006-2012
Table 29: The US Other Central Nervous System Disorders Clinical Studies, 2006-2012
Figure 31: The US Other Central Nervous System Diseases Clinical Research Market Size on The Basis of Revenue in USD Million, 2006-2012
6.2.12. The US Other Central Nervous System Disorders Clinical Research Market Future Outlook and Projections by Revenue, 2013-2017
Figure 32: The US Other Central Nervous System Diseases Clinical Research Market Future Projections on the Basis of Revenue in USD Million, 2013-2017
6.3. The US Central Nervous System Clinical Research Market Future Outlook and Projections, 2006-2012
Figure 33: The US Central Nervous System Clinical Research Market Future Projections on the Basis of Revenues in USD Million, 2013-2017
7. The US Cardiovascular Clinical Research Market
7.1. The US Cardiovascular Clinical Research Market Size by Revenue, 2006-2012
Figure 34: The US Cardiovascular Clinical Research Market Size on The Basis of Revenue in USD Million, 2006-2012
Table 30: The US Cardiovascular Clinical Studies Conducted in Units, 2006-2012
7.2. The US Cardiovascular Clinical Research Market Segmentation, 2006-2012
Figure 35: The US Cardiovascular Clinical Research Market Segmentation by Major Therapeutic Areas on the Basis of Revenue in Percentage (%), 2006-2012
7.2.1. The US Coronary Artery Disease Clinical Research Market Size, 2006-2012
Table 31: The US Estimated Prevalence, Incidence and Reoccurrence of CAD, 2011 & 2012
Figure 36: The US Coronary Artery Disease Clinical Research Market Size on The Basis of Revenue in USD Million, 2006-2012
Table 32: The US Coronary Artery Disease Clinical Studies Conducted in Units, 2006-2012
7.2.2. The US Coronary Artery Disease Clinical Research Market Future Outlook and Projections, 2013-2017
Figure 37: The US Coronary Artery Disease Clinical Research Market Future Projections on the Basis of Revenue in USD Million, 2013-2017
7.2.3. The US Heart Failures Clinical Research Market Size by Revenue, 2006-2012
Table 33: The US Estimated Prevalence and Incidence of Heart Failures, 2012
Figure 38: The US Heart Failures Clinical Research Market Size on The Basis of Revenue in USD Million, 2006-2012
Table 34: The US Heart Failures Clinical Studies Conducted in Units, 2006-2012
7.2.4. The US Heart Failures Clinical Research Market Future Projections, 2013-2017
Figure 39: The US Heart Failures Clinical Research Market Future Projections on the Basis of Revenues in USD Million, 2013-2017
7.2.5. The US Other Cardiovascular Diseases Clinical Research Market Size by Revenue, 2006-2012
Figure 40: The US Other Cardiovascular Diseases Clinical Research Market Size on The Basis of Revenue in USD Million, 2006-2012
7.2.6. The US Other Cardiovascular Diseases Clinical Research Market Size Future Outlook and Projections, 2013-2017
Figure 41: The US Other Cardiovascular Diseases Clinical Research Market Future Projections on the Basis of Revenues in USD Million, 2013-2017
7.3. The US Cardiovascular Clinical Research Market Future Outlook and Projections by Revenue, 2013-2017
Figure 42: The US Cardiovascular Clinical Research Market Future Projections on the Basis of Revenue in USD Million, 2013-2017
8. The US Infectious Diseases Clinical Research Market
8.1. The US Infectious Diseases Clinical Research Market Size by Revenue, 2006-2012
Figure 43: The US Infectious Diseases Clinical Research Market Size on The Basis of Revenue in USD Million, 2006-2012
Table 35: The US Infectious Diseases Clinical Studies Conducted in Units, 2006-2012
8.2. The US Infectious Diseases Clinical Research Market Segmentation, 2006-2012
Figure 44: The US Infectious Diseases Clinical Research Market Segmentation by Major Therapeutic Areas on the Basis of Revenue in Percentage (%), 2006-2012
8.2.1. The US HIV/AIDS Clinical Research Market Size by Revenue, 2006-2012
Table 36: The US HIV/AIDS Incidence and Prevalence, 2010-2012
Figure 45: The US HIV/AIDS Clinical Research Market Size on the Basis of Revenues in USD Million, 2006-2012
Table 37: The US HIV/AIDS Clinical Studies Conducted in Units, 2006-2012
8.2.2. The US HIV/AIDS Clinical Research Market Future Outlook and Projections, 2013-2017
Figure 46: The US HIV/AIDS Clinical Research Market Future Projections on the Basis of Revenues in USD Million, 2013-2017
8.2.3. The US Hepatitis (A, B and C) Clinical Research Market Size by Revenue, 2006-2012
Table 38: The US Incidence of Hepatitis A, B and C in the Population, 2006-2010
Figure 47: The US Hepatitis (A, B and C) Clinical Research Market Size on The Basis of Revenue in USD Million, 2006-2012
Table 39: The US Hepatitis (A, B and C) Clinical Studies Conducted in Units, 2006-2012
8.2.4. The US Hepatitis (A, B and C) Clinical Research Market Future Outlook and Projections by revenue, 2013-2017
Figure 48: The US Hepatitis (A, B and C) Clinical Research Market Future Projections on the Basis of Revenues in USD Million, 2013-2017
8.2.5. The US Other Infectious Diseases Clinical Research Market Size, 2006-2012
Figure 49: The US Other Infectious Diseases Clinical Research Market Size on The Basis of Revenues in USD Million, 2006-2012
8.2.6. The US Other Infectious Diseases Clinical Research Market Future Outlook and Projections, 2006-2012
Figure 50: The US Other Infectious Diseases Clinical Research Market Future Projections on the Basis of Revenues in USD Million, 2013-2017
8.3. The US Infectious Diseases Clinical Research Market Future Outlook and Projections By Revenue, 2013-2017
Figure 51: The US Infectious Diseases Clinical Research Market Future Projections on the Basis of Revenue in USD Million, 2013-2017
9. The US Metabolic Disorders Clinical Research Market
9.1. The US Metabolic Disorders Clinical Research Market Size by Revenue, 2006-2012
Figure 52: The US Metabolic Disorders Clinical Research Market Size on the Basis of Revenue in USD Million, 2006-2012
Table 40: The US Metabolic Disorders Clinical Studies Conducted in Units, 2006-2012
9.2. The US Metabolic Disorders Clinical Research Market Segmentation, 2006-2012
Figure 53: The US Metabolic Disorders Clinical Research Market Segmentation by Major Therapeutic Areas on the Basis of Revenue in Percentage (%), 2006-2012
9.2.1. The US Diabetes Clinical Research Market Size by Revenue, 2006-2012
Table 41: The US Diagnosed and Undiagnosed Diabetes Cases among People aged 20 years or older, 2010
Figure 54: The US Diabetes Clinical Research Market Size on The Basis of Revenue in USD Million, 2006-2012
Table 42: The US Diabetes Clinical Studies Conducted in Units, 2006-2012
9.2.2. The US Diabetes Clinical Research Market Future Outlook and Projections by Revenue, 2013-2017
Figure 55: The US Diabetes Clinical Research Market Future Projections on the Basis of Revenue in USD Million, 2013-2017
9.2.3. The US Other Metabolic Disorders Clinical Research Market Size by Revenue, 2006-2012
Figure 56: The US Other Metabolic Disorders Clinical Research Market Size on The Basis of Revenue in USD Million, 2006-2012
9.2.4. The US Other Metabolic Disorders Clinical Research Market Future Outlook and Projections, 2013-2017
Figure 57: The US Metabolic Disorders Clinical Research Market Future Projections on the Basis of Revenue in USD Million, 2013-2017
9.3. The US Metabolic Disorders Clinical Research Market Future Outlook and Projections, 2013-2017
Figure 58: The US Metabolic Disorders Clinical Research Market Future Projections on the Basis of Revenue in USD Million, 2013-2017
10. The US Other Therapeutic Area Clinical Research Market
10.1. The US Other Therapeutic Area Clinical Research Market Size by Revenue, 2006-2012
Figure 59: The US Other Therapeutic Area Clinical Research Market Size on The Basis of Revenues in USD Million, 2006-2012
10.2. The US Other Therapeutic Area Clinical Research Market Future Outlook and Projections, 2013—2017
Figure 60: The US Other Therapeutic Area Clinical Research Market Future Projections on the Basis of Revenues in USD Million, 2013-2017
 

The US Clinical Research Market-Rules, Trends Pages : 7 USD 50    Market Size Reports Market Size Reports

 11. FDA Rules Governing the US Clinical Research Market

Table 43: The US FDA Acts and Codes Governing the Drug Development Market
12. Trends and Developments in the US Clinical Research Market
Reduced Government Spending on Clinical Research
Table 44: The US Fiscal Budgets and Funding to NIH, FY 2006- FY 2012
Off shoring Clinical trials to Emergent Markets
Evolution of E-clinical trials
Patent Expiry of Several Branded Drugs
Table 45: The US List of Major Drugs Losing Patent, 2013-2016
Privatization of CROs
Table 46: The Major CROs in the US which went private
Strategic Alliances between Pharmaceutical Companies and CROs
Table 47: The US Strategic Alliances between Pharmaceutical Companies and CROs, 2012
 

The US Clinical Research Market-Opportunity, Drivers, Restraints Pages : 5 USD 50    Market Size Reports Market Size Reports

 13. Opportunities, Drivers and Restraints

Opportunities
Drivers
Restraints
14. Role of Academic Institutes in the US in Conducting Clinical Research
Table 48: Major Academic Institutions Involved in the US Clinical Research Market
 

The US Clinical Research Market-Market Share, Company Profiles Pages : 18 USD 150    Market Size Reports Market Size Reports

 15. Market Share of Major Players in the US Clinical Research Market, 2012

Figure 61: Market Share of Major Players in the US Clinical Research Market in Percentage, 2012
16. Company Profiles of the Major Players
16.1. Quintiles
Company Overview
Business Strategies
Financial Performance
Figure 62: The US Revenue of Quintiles in USD Million, 2011-2012
Table 49: Strategic Partnerships of Quintiles, 2010-2013
16.2. Covance Inc.
Company Overview
Business Strategies
Financial Performance
Figure 63: The US Revenue of Covance Inc. in USD Million, 2006-2012
Table 50: Strategic Partnerships and Alliances by Covance, 2010-2013
16.3. PPD
Company Overview
Business Strategies
Financial Performance
Figure 64: The US Revenue of PPD in USD Million, 2006-2010
Table 51: Strategic Alliances of PPD
16.4. INC Research
Company Overview
Business Strategies
Table 52: Strategic Partnerships of INC Research, 2011
16.5. Inventiv Health Care
Company Overview
Business Strategies
Financial Performance
Figure 65: Global Revenue of Inventiv Health in USD Million, 2006-2009
Table 53: Strategic Partnerships of Inventiv Health Care, 2010-2013
16.6. Parexel
Company Overview
Business Strategies
16.7. ICON
Company Overview
Business Strategies
Financial Performance
Figure 66: The US Revenue of ICON in USD Million, 2007-2012
Table 54: Strategic Partnerships and Alliances by ICON, 2010-2012
16.8. PRA
Company Overview
Business Strategies
Table 55: Strategic Partnerships of PRA International, 2007-2013
 

The US Clinical Research Market-Outlook and Macro Economy Pages : 9 USD 100    Market Size Reports Market Size Reports

 17. The US Clinical Research Market Future Outlook and Projections, 2013-2017

17.1. Cause and Effect Relationship between Dependent and Independent Factors Prevailing In the Us Clinical Research Market
Table 56 : Cause and Effect Relationship Analysis between Industry Factors and Expected Prospects in the US Clinical Research Market
17.2. The US Clinical Research Market Future Projections, 2013-2017
Figure 67: The US Clinical Research Market Future Projections on the Basis of Revenues in USD Million, 2013-2017
18. Macro Economic and Industry factors: Historical and Projections
18.1. The US Pharmaceutical Companies Domestic R&D Expenditure, 2006-2017
Figure 68: The US Pharma Companies Domestic R&D Expenditure in USD Million, 2006-2017
18.2. The US GDP, 2006-2017
Figure 69: The US GDP in USD Million, 2006-2017
18.3. The US Aged population, 2006-2017
Figure 70: The US Aged population in Million, 2006-2017
18.4. The US Health Expenditure, 2006-2017
Figure 71: The US Health Expenditure in USD Million, 2006-2017
18.5. NIH Funding to Clinical Research, 2006-2017
Figure 72: The US National Institutes of Health Funding to Clinical Research in USD Million, 2006-2017